One of the most powerful tools we use to understand your health is something called a biomarker.
Biomarkers provide objective insight into what is happening inside your body—often before symptoms fully develop—allowing us to move beyond guesswork and toward personalized, data-driven care.
Once a diagnosis is established, biomarkers also help your clinician monitor your progress over time, guiding whether your treatment plan is working or needs to be adjusted.
However, what many patients do not realize is that the real value of biomarkers is not just in testing them once, it is in tracking them over time
What Is a Biomarker?
A biomarker is a measurable indicator of what is happening in your body to assess health status, identify disease risk, guide treatment decisions and monitor response to therapy.
Biomarkers can include:
- Blood tests
- Hormone levels
- Nutrient status
- Inflammatory markers
- Metabolic markers
- Immune system signals
Inflammatory Biomarkers: A Foundation of Precision Medicine
A very important category we evaluate is inflammation. Why? Because inflammation is a root driver of many chronic conditions, including:
- Cardiovascular disease
- Autoimmune conditions
- Neurodegenerative disorders
- Metabolic dysfunction
Some examples of inflammatory biomarkers include:
- C-reactive protein (CRP)
- Erythrocyte sedimentation rate (ESR)
- Ferritin
- Cytokines like IL-6
- D-Dimer
- TGF Beta 1
These markers help us detect hidden inflammation, even when you feel “fine.”
Inflammation is strongly linked to outcomes like cardiovascular events, fatigue, and overall health decline, making it a critical area to monitor.
Beyond Inflammation: Other Key Biomarkers We Evaluate
While inflammation is central, it is only one piece of the puzzle. We must look at a broader network of biomarkers, from metabolism, neurological, immunity to stress markers, especially oxidative stress to the cellular level. Some of these markers can include (but are not limited to):
- Metabolic Markers: Glucose, insulin, HbA1c, lipid profiles, indicators of metabolic flexibility
- Nutritional Biomarkers: Vitamins & Minerals, blood markers, micronutrient status, gut dysbiosis
- Neurological & Cognitive Markers: Markers of oxidative stress, neuroinflammatory indicators
- Immune System Markers: White blood cell patterns, immunoglobulins autoimmune markers
- Oxidative Stress & Cellular Health: Markers of mitochondrial function, oxidative DNA damage indicators
- Endocrine/Reproductive Markers: sex hormones such as estrogen, progesterone and testosterone, cortisol, ACTH
These biomarkers help us understand not just whether something is wrong, but also why it may be happening. While there are many markers we could evaluate, our approach is personalized: we start with the basics and then explore more in-depth markers as your individual health patterns and potential issues emerge.
Why We Do Not Rely on Just One Test
A single biomarker is like a snapshot, but your health is a movie, not a single photograph.
No one marker can diagnose a condition on its own. Many biomarkers, especially inflammatory ones—are non-specific, meaning they can be elevated for multiple reasons.
That is why we, look at patterns, not isolated values, combine multiple markers for context
Integrate labs with your symptoms and history
Why We Re-Test Biomarkers
Biomarkers are specifically designed to reflect your body’s response to interventions. This is one of the most important parts of your care.
- Track Progress
When we start a treatment plan—whether it is nutrition, supplementation, detoxification, or medication, we expect your biomarkers to change. Re-testing helps us answer certain questions: Is inflammation going down? Is your metabolism improving? Are nutrient levels being restored?
- To Personalize Your Treatment
Your body is unique. Two patients may start with similar lab values but respond very differently to the same treatment. Re-testing allows us to adjust protocols in real time, avoid over- or under-treatment, and to optimize your outcomes
- To Account for Natural Variability
Biomarkers can naturally fluctuate due to factors like stress, sleep, minor illness, or differences between labs. Repeating measurements over time helps improve accuracy and allows us to distinguish true trends from temporary or short-term changes.
- To Monitor Long-Term Risk
Some biomarkers, especially inflammatory ones, are tied to long-term disease risk. Research shows that measuring these markers at appropriate intervals over time provides a more reliable picture of health than relying on a single test.
Why We Wait Weeks to Months Before Re-Testing
Patients often ask: “Why don’t we recheck sooner?” The reason is because over-testing, testing too soon, or even self-interpretation can be problematic.
It may seem like more testing may lead to better answers—but that is not always the case.
Testing too frequently or too soon can create confusion instead of clarity.
Here’s why:
- Biomarkers need time to change
Your body does not shift overnight. Testing too early may show little to no change, even when progress is happening. - Normal biological fluctuations can be misleading
Stress, poor sleep, minor illness, or even exercise can temporarily alter lab values. - Too much data can lead to over-interpretation
Without proper context, small variations may be mistaken for meaningful problems. - It can lead to unnecessary anxiety or treatment changes
Reacting too quickly to early or insignificant changes can derail an otherwise effective plan. - Or the lab result itself may simply be incorrect.
In most cases, allowing 4–12 weeks between tests gives us a much more accurate and clinically meaningful picture.
Why Self-Interpreting Labs Can Lead to Confusion and Stress
In today’s world, it is very common to look up lab results online or ask AI tools for interpretation. While access to information can be helpful, it can also be misleading when it comes to medical data.
The reality is, lab interpretation is complex and requires clinical training, context, and experience.
When biomarkers are interpreted in isolation:
- A normal variation may be mistaken for disease
- A non-specific marker may be linked to the wrong condition
- Patterns that matter may be missed entirely
This can lead patients to believe they have a condition they do not actually have—creating unnecessary fear, stress, and confusion.
Online resources and AI tools can provide general education, but they:
- Do not know your full medical history
- Cannot assess clinical context
- Are not licensed to diagnose or treat
That is why interpretation should always be done in partnership with a qualified clinician who understands how to connect the full picture.
The Big Picture: Data-Driven, Personalized Care
In the end, biomarkers help us identify root causes, create targeted treatment plans, objectively track your progress, and adjust care based on real data. But most importantly, they allow us to partner with you in your health journey—using evidence, not guesswork. The goal is not more data—it is the right data, at the right time, interpreted in the right context.
References
- Haneef, Z., et al. (2023). The role of clinical assessment in the era of biomarkers. Diagnostics.
- Institute of Medicine. (2010). Evaluation of biomarkers and surrogate endpoints in chronic disease. National Academies Press.
- Kaur, G., et al. (2023). Battle of the biomarkers of systemic inflammation. Biomedicines.
- Kaysen, G. A. (2009). Biochemistry and biomarkers of inflamed patients: Why look, what to assess. Clinical Journal of the American Society of Nephrology, 4(Suppl 1), S56–S63.
- Moriarity, D. P., et al. (2022). Stability of inflammatory biomarkers in healthy adults: A systematic review and meta-analysis. Brain, Behavior, and Immunity.
- Tektonidou, M. G., & Ward, M. M. (2011). Validation of new biomarkers in systemic autoimmune diseases. Nature Reviews Rheumatology, 7, 708–717.
- Wu, A. H. B. (2024). Biological variation: An important but unappreciated clinical laboratory test metric. The Journal of Applied Laboratory Medicine, 9(3), 423–425. https://doi.org/10.1093/jalm/jfae018
